期刊文献+

卵巢透明细胞腺癌的临床及病理鉴别诊断 被引量:2

Clinical and Pathological Differential Diagnosis of Ovarian Clear Cell Adenocarcinoma
下载PDF
导出
摘要 目的探讨临床及病理对卵巢透明细胞腺癌与其他肿瘤的的诊断及其鉴别诊断。方法应用免疫组化的方法,采用不同的抗体标记5例卵巢透明细胞腺癌,观察其表达,探讨与其他肿瘤的鉴别诊断。结果 5例卵巢透明细胞腺癌的大体和镜下形态不完全相同,抗体CK、EMA、LeuM1、B72.3呈弥漫强阳性,阳性部位主要位于细胞浆,CA125、CEA部分或局灶阳性;而WT-1、HCG、AFP、D2-40、CD30、TG均为阴性。结论卵巢透明细胞腺癌的诊断必须结合临床与病理综合判定。 Objective To explore the clinical and pathological diagnosis between ovarian clear cell adenocarcinoma and other tumors. Methods Immunohistochemical method was employed to label 5 cases of ovarian clear cell adenocarcinoma with different antibody. Then, the differential diagnosis between ovarian clear cell adenocarcinoma and other tumors was observed and discussed. Results The gross and microscopical morphology of all 5 case of ovarian clear cell adenocarcinoma were not identical: all cases showed diffuse and strong staining for CK, EMA, LeuM 1, B72.3; the staining was mainly located in the cytoplasma while local positive for CA 125, CEA, but all tumor cells were negative for WT-1, HCG, AFP, D2-40, CD30, TG. Conclusions The diagnosis of ovarian clear cell carcinoma must be associated with clinical and pathological analysis for comprehensive diagnosis.
出处 《临床医学工程》 2010年第5期17-18,共2页 Clinical Medicine & Engineering
基金 厦门市科技局资助项目(编号:2007z30554017)
关键词 卵巢癌 透明细胞腺癌 病理鉴别 免疫组化 Ovarian carcinoma Clear cell adenocarcinoma Pathological differential diagnosis Immunohistochemistry
  • 相关文献

参考文献7

二级参考文献47

  • 1陈晓军,丰有吉.CAP方案治疗卵巢上皮性癌178例远期疗效分析[J].复旦学报(医学版),2005,32(3):346-348. 被引量:4
  • 2Hart WR. Pathology of malignant and borderline (low malignant potential) epithelial tumors of ovary. In: Coppleson M, ed. Gynecologic oncology fundamental principles and clinical practice. New York: Churchill Livingstone, 1992. 863-887.
  • 3Thingpen JT, Blessing JA, Ball H, et al. Phase Ⅱ trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study. J Clin Oncol, 1994, 12: 1748-1753.
  • 4Sugiyama T, Kamura T, Kigawa J, et al. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistant to platinum-based chemotherapy. Cancer, 2000, 88: 2584-2589.
  • 5Kita T, Kikuchi Y, Kudoh K, et al. Exploratory study of effective chemotherapy to clear cell carcinoma of the ovary. Oncol Rep, 2000, 7: 327-331.
  • 6Behbakht K, Randall TC, Benjamin I, et al. Clinical characteristics of clear cell carcinoma of the ovary. Gynecol Oncol, 1998, 70: 255-258.
  • 7Jenison EL, Montag AG, Griffiths CT, et al. Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma. Gynecol Oncol, 1989, 32: 65-71.
  • 8Goff BA, Sainz de la Cuesta R, Muntz HG, et al. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage Ⅲ disease. Gynecol Oncol, 1996, 60: 412-417.
  • 9Gorai I, Nakazawa T, Miyagi E, et al. Establishment and charac- terization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties. Gynecol Oncol, 1995, 57: 33-46.
  • 10Shimizu Y, Umezawa S, Hasumi K. A phase Ⅱ study of combined CPT-11 and mitomycin-C in platinum refractory clear cell and mucinous ovarian carcinoma. Ann Acad Med Singapore, 1998, 27: 650-656.

共引文献34

同被引文献11

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部